Trevena Announces New Topline OLINVYK Data Highlighting Reduced Cost per Admission from ARTEMIS Real-World Outcomes Study Jun 26, 2023 7:00 am EDT
Trevena Announces Receipt of Milestone Payment From Partner in China Jiangsu Nhwa Pharmaceutical May 31, 2023 7:00 am EDT
Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones May 30, 2023 7:00 am EDT
Trevena Announces Initial Topline OLINVYK Data from ~200 Patient Real-World Clinical Outcomes Study Mar 30, 2023 7:02 am EDT